Mather Group LLC. Has $447,000 Stock Position in The Clorox Company (NYSE:CLX)

Mather Group LLC. grew its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 59.4% during the second quarter, HoldingsChannel.com reports. The firm owned 3,273 shares of the company’s stock after acquiring an additional 1,220 shares during the quarter. Mather Group LLC.’s holdings in Clorox were worth $447,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. CIBC Private Wealth Group LLC increased its holdings in Clorox by 0.5% in the 4th quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock valued at $1,982,000 after buying an additional 66 shares during the period. Lindbrook Capital LLC raised its position in Clorox by 6.2% during the first quarter. Lindbrook Capital LLC now owns 1,182 shares of the company’s stock valued at $181,000 after purchasing an additional 69 shares in the last quarter. First National Bank of Omaha lifted its stake in Clorox by 1.5% during the fourth quarter. First National Bank of Omaha now owns 5,975 shares of the company’s stock worth $852,000 after purchasing an additional 86 shares during the last quarter. Hartford Financial Management Inc. boosted its holdings in shares of Clorox by 57.1% in the 4th quarter. Hartford Financial Management Inc. now owns 256 shares of the company’s stock valued at $37,000 after purchasing an additional 93 shares in the last quarter. Finally, Retirement Planning Group LLC boosted its holdings in shares of Clorox by 4.2% in the 1st quarter. Retirement Planning Group LLC now owns 2,325 shares of the company’s stock valued at $356,000 after purchasing an additional 94 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Trading Up 0.4 %

NYSE:CLX traded up $0.56 on Tuesday, reaching $143.23. 1,955,234 shares of the stock traded hands, compared to its average volume of 1,271,278. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $165.40. The company’s 50 day moving average is $134.13 and its 200-day moving average is $142.37. The firm has a market capitalization of $17.79 billion, a price-to-earnings ratio of 74.54, a price-to-earnings-growth ratio of 1.97 and a beta of 0.39.

Clorox Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 30th. Stockholders of record on Wednesday, August 14th will be given a dividend of $1.22 per share. The ex-dividend date is Tuesday, August 13th. This is a boost from Clorox’s previous quarterly dividend of $1.20. This represents a $4.88 annualized dividend and a dividend yield of 3.41%. Clorox’s dividend payout ratio is 248.71%.

Wall Street Analysts Forecast Growth

CLX has been the subject of several recent analyst reports. JPMorgan Chase & Co. dropped their price objective on Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a research report on Friday. Citigroup reduced their price target on shares of Clorox from $150.00 to $145.00 and set a “neutral” rating on the stock in a research note on Wednesday, July 10th. Wells Fargo & Company lowered their price objective on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research report on Wednesday, July 10th. TD Cowen began coverage on shares of Clorox in a research report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 target price on the stock. Finally, DA Davidson decreased their target price on shares of Clorox from $162.00 to $153.00 and set a “neutral” rating on the stock in a research note on Friday. Six analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $141.94.

Read Our Latest Report on Clorox

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.